Increased mortality despite successful multifactorial cardiovascular risk reduction in healthy men. 40-year follow-up of the Helsinki businessmen study intervention trial

25 August 2018 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Professor Timo Strandberg

Helsinki University Hospital, Helsinki (Finland)

6 More presentations in this session

Presentation thumbnail

Assessing cardiovascular risk in people with atherosclerotic vascular disease on intensive statin therapy

Associate Professor B. Mihaylova (London, GB)

Presentation thumbnail

Added predictive value of follow-up blood-pressure measurements after alteration of therapy on cardiovascular risk in patients with hypertension

Ms N. Jaspers (Utrecht, NL)

Abstract Slides

Presentation thumbnail

Optimizing outreach strategy to identify individuals at risk for diabetes and/or cardiovascular disease: a study of the Sodertalje municipality in Sweden

Doctor B. Shahim (Stockholm, SE)

Abstract Slides

Presentation thumbnail

Associations between very low concentrations of LDL-Cholesterol, hsCRP and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) study

Professor M. Banach (Lodz, PL)

Abstract Slides

Presentation thumbnail

Sex hormone-binding globulin, aging, and cardiovascular risk

Ms E. Aribas (Rotterdam, NL)

Abstract Slides

Access the full session

Session thumbnail

Controversies in cardiovascular risk assessment and prevention

The Event

ESC Congress 2018

25 August - 29 August 2018

You may be interested in

Congress Presentation

Making personalised prevention everyone's business

Congress Presentation

Saving hearts, extending lives: the impact of risk prevention on lifetime estimates in Germany

Congress Presentation

Cardiovascular prevention in older adults

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources